Medical Record Number

Sodium Chloride

The manipulation of a cellular therapy product such that a specific cell population(s) is depleted.

Nucleic Acid Testing

Not done

That which is not free of pathogenic and/or nonpathogenic microorganisms, including spores.

Any cellular therapy product that does not completely meet the requirements specified by these policies or procedures.

Non-reactive

All cells other than red blood cells and platelets.

A nurse with a graduate degree in advanced practice nursing providing patient services in defined areas of practice.  These services are provided in collaboration with other health professionals.  A type of Mid-Level Practitioner.

Optical density

The process by which the results of a therapeutic procedure are formally assessed.

Abnormally low counts in all cell lineages.

The minimal essential elements that must be affixed to all cellular therapy product containers.

Producing or capable of producing disease.

Peripheral blood mononuclear cells

Phosphate Buffered Saline

Phycoerythrin

Blood that has been enriched for mononuclear white blood cells (Lymphocytes and Monocytes).  This may be accomplished with the use of density gradient separation medium or with a cell processor.  May be referred to as PBMC.

Hematopoietic cell with multilineage potential obtained from peripheral blood rather than the bone marrow.  Hematopoietic progenitor cells are induced to circulate following administration of hematopoietic growth factors (e.g. G-CSF, GM-CSF, SCF, IL-3) or following recovery from myeloablation or a combination.  These are normally collected by the process of apheresis and are admixed with other peripheral mononuclear cells.  May also be referred to as peripheral blood stem cells (PBSC).  Proper name is Hematopoietic Progenitor Cells, Apheresis (HPC-A).  This terminology should be used in all relevant laboratory documents.